Evidence map›Paper›PMID 35622149›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2022

Discussing POLST-facilitated hospice care enrollment in patients with terminal cancer.

Ho Jung An, Hyun Jeong Jeon, Sang Hoon Chun, Hyun Ae Jung, Hee Kyung Ahn, Kyung Hee Lee, Min-Ho Kim, Ju Hee Kim, Jaekyung Cheon, Su-Jin Koh

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Pediatric Oncology Hospice: A Comprehensive Review.The American journal of hospice & palliative care · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 1 country.

Ho Jung AnDepartment of Medical Oncology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
Hyun Jeong JeonDepartment of Internal Medicine, Seoul Medical Center, Seoul, South Korea.
Sang Hoon ChunDivision of Medical Oncology, Department of Internal Medicine, Bucheon St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
Hyun Ae JungDepartment of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Dongtan, South Korea.
Hee Kyung AhnDivision of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, South Korea.
Kyung Hee LeeDepartment of Internal Medicine, Yeungnam University College of Medicine, Daegu, South Korea.
Min-Ho KimEwha Institute of Convergence Medicine, Ewha Womans University Mokdong Hospital, Seoul, South Korea.
Ju Hee KimDepartment of Hematology and Oncology, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, 877, Bangeojinsunhwando-ro, Dong-gu, Ulsan, 44033, South Korea.
Jaekyung CheonDepartment of Hematology and Oncology, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, 877, Bangeojinsunhwando-ro, Dong-gu, Ulsan, 44033, South Korea.
Su-Jin KohDepartment of Hematology and Oncology, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, 877, Bangeojinsunhwando-ro, Dong-gu, Ulsan, 44033, South Korea. sujinkoh@hanmail.net.
Ulsan University Hospital · KREwha Womans University · KRGachon University Gil Medical Center · KRHallym University Dongtan Sacred Heart Hospital · KRSeoul Medical Center · KRThe Catholic University of Korea Bucheon St. Mary's Hospital · KRThe Catholic University of Korea St. Vincent's Hospital · KRYeungnam University College

Funding

Catholic Medical Center Research Foundation the program year of 2022KCSG PC17-01
6 · The paper itself

Abstract

purposeA multicenter prospective study to evaluate the feasibility of Physician Orders for Life-Sustaining Treatment (POLST) in oncology practice was conducted between June and December 2017. Factors associated with POLST completion and follow-up outcomes were analyzed.

methodsPatients with terminal cancer, aged ≥ 20 years and capable of communicating, were enrolled from seven hospitals. Demographic data were collected and updated in February 2021. Descriptive statistics and logistic regression analyses were conducted.

resultsAmong 336 patients, 105 (31.3%) completed POLST, which was more common in male (p = 0.029), patients with better performance (p < 0.001), longer duration of follow-up (p = 0.037), and those living with children (p = 0.023). Male (odds ratio [OR], 2.30; 95% confidence interval [CI], 1.17-3.51; p = 0.012), having good performance status (OR, 2.38; 95% CI, (1.35-4.19); p = 0.003), transferred from other departments (OR, 0.50; 95% CI, (0.26-0.98); p = 0.045), and living with children (OR, 1.94; 95% CI, (1.11-3.47); p = 0.020) were significant predictors of POLST completion. Patients who completed POLST were more likely to enroll in hospice care (p = 0.012) or experience out-of-hospital death (p = 0.016) at end-of-life (EOL). POLST completion showed a strong association with hospice enrollment at EOL (OR, 2.61; 95% CI, (1.08-6.32); p = 0.033).

conclusionGender, patient performance, timing of POLST discussion, and type of household were associated with POLST completion. Earlier discussions on POLST could reinforce hospice enrollment or non-aggressive EOL care.

Indexed as

Advance Care PlanningHospice CareNeoplasmsTerminal CareAdvance DirectivesChildHumansMaleProspective StudiesResuscitation OrdersHospicesOut-of-hospital deathPOLSTTerminal cancer

Identifiers

PMID35622149
OpenAlexW4281673922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.